Hypoglycemic Agents

"Hypoglycemic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Substances which lower blood glucose levels.

Descriptor ID	D007004
MeSH Number(s)	D27.505.696.422
Concept/Terms	Hypoglycemic Agents Hypoglycemic Agents Agents, Hypoglycemic Antihyperglycemics Antihyperglycemic Agents Agents, Antihyperglycemic Hypoglycemic Drugs Drugs, Hypoglycemic Hypoglycemics Hypoglycemic Effect Hypoglycemic Effect Effect, Hypoglycemic Hypoglycemic Effects Effects, Hypoglycemic Antidiabetics Antidiabetics Antidiabetic Drugs Drugs, Antidiabetic Antidiabetic Agents Agents, Antidiabetic

Below are MeSH descriptors whose meaning is more general than "Hypoglycemic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Hypoglycemic Agents [D27.505.696.422]

Below are MeSH descriptors whose meaning is more specific than "Hypoglycemic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hypoglycemic Agents" by people in this website by year, and whether "Hypoglycemic Agents" was a major or minor topic of these publications.

Bar chart showing 159 publications over 26 distinct years, with a maximum of 15 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	2	1	3
2002	3	1	4
2003	1	0	1
2004	3	2	5
2005	4	2	6
2006	3	2	5
2007	3	2	5
2008	2	4	6
2009	4	3	7
2010	3	3	6
2011	2	4	6
2012	3	2	5
2013	3	0	3
2014	11	4	15
2015	8	2	10
2016	7	1	8
2017	3	3	6
2018	3	2	5
2019	5	3	8
2020	3	6	9
2021	1	3	4
2022	1	4	5
2023	0	9	9
2024	8	2	10
2025	6	1	7
2026	1	0	1

Below are the most recent publications written about "Hypoglycemic Agents" by people in Profiles.

da Silva AMP, Janu?rio Campos Cardoso L, Batista S, Gon?alves OR, Paranhos T, Teixeira IPS, Guimar?es PD, Espinosa Franco B, Cal H, Salles JEN, Perry G, H?ilund-Carlsen PF, Santos DH. Tirzepatide versus semaglutide for the prevention of mild cognitive impairment, dementia, and Alzheimer's disease in type 2 diabetes: A real-world, retrospective cohort study. J Diabetes Complications. 2026 May; 40(5):109306.

View in: PubMed
Hassan S, Sobers NP, Paul-Charles J, Herbert J, Dharamraj K, Galusha D, Cruz E, Garcia-Rivera E, Fredericks L, Arniella G, Cattamanchi A, Adams OP, Maharaj RG, Nazario CM, Nunez M, Nunez-Smith M. Diabetes prevention in the Caribbean using lifestyle intervention and Metformin escalation (LIME): results from a quasi-experimental study. BMC Public Health. 2025 Nov 22; 25(1):4409.

View in: PubMed
Ibraheem O, Ibikunle PD, Gabriel-Ajobiewe RAO, Oyeniran OH, Sodipe GO, Komolafe TR, Komolafe K, Oyewole OT, Ogwa EC, Jeje TO. Bacillus subtilis 7A Enhances the Nutritional Quality of Velvet Bean (Mucuna pruriens Linn.) Seeds and Potentiates Its Role in the Management of Type II Diabetes Mellitus. J Food Sci. 2025 Aug; 90(8):e70446.

View in: PubMed
Wang W, Davis PB, Qi X, Gurney M, Perry G, Volkow ND, Kaelber DC, Xu R. Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study. J Alzheimers Dis. 2025 Aug; 106(4):1509-1522.

View in: PubMed
Sobhani NC, Huang Y, Venkatesh KK, Wright JD, Friedman AM, Wen T. Diabetes Technology Use in Pregnancies with Type 1 Diabetes in the United States from 2009 to 2020. Am J Perinatol. 2026 03; 43(4):453-460.

View in: PubMed
Mousavi M, Moridi Farimani M, Kashfi K, Ghasemi A. Antidiabetic Potential of Sophora Species: Mechanisms, Bioactive Constituents, and Therapeutic Prospects. Planta Med. 2025 Sep; 91(10-11):546-557.

View in: PubMed
Farahani A, Farahani A, Kashfi K, Ghasemi A. Inhibition of hepatic gluconeogenesis in type 2 diabetes by metformin: complementary role of nitric oxide. Med Gas Res. 2025 Dec 01; 15(4):507-519.

View in: PubMed
Brai B, Amosun B, Komolafe T, Joseph R, Komolafe K. In Vitro Antidiabetic Potential and Influence of Neem Oil Extract on Biochemical Indices of Toxicity Following Sub-Acute Administration in Rats. Niger J Physiol Sci. 2025 Jan 14; 39(1):77-85.

View in: PubMed
Davidson MB. The Effective Use by Primary Care Clinicians of a Comprehensive Computerized Insulin Dose Adjustment Algorithm. J Diabetes Sci Technol. 2026 May; 20(3):1021-1027.

View in: PubMed
Brai BIC, Joseph RO, Komolafe TR, Amosun BE, Crown OO, Komolafe K, Ogungbe IV. Neem seed oil ameliorates diabetic phenotype by suppressing redox imbalance, dyslipidaemia and pro-inflammatory mediators in a rodent model of type 2 diabetes. Arch Physiol Biochem. 2025 Jun; 131(3):351-365.

View in: PubMed

People

Explore

Similar Concepts

Top Journals